Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Cynata completes private placement

    Cynata Therapeutics Ltd. (ASX:CYP), Armadale, Australia Business: Gene/Cell therapy Date completed: 2015-07-15 Type: Private placement Raised: A$5 million ($3.7 million) Shares: 6.7 million Price: A$0.75 Shares after …

    Published on 7/20/2015
  • DBV completes follow-on

    DBV Technologies S.A. (Euronext:DBV; NASDAQ:DBVT), Bagneux, France Business: Inflammation, Diagnostic Date completed: 2015-07-15 Type: Follow-on Raised: $244.8 million Shares: 7.2 million Price: $34 Shares after …

    Published on 7/20/2015
  • Delcath completes follow-on

    Delcath Systems Inc. (NASDAQ:DCTH), New York, N.Y. Business: Drug delivery, Cancer Date completed: 2015-07-16 Type: Follow-on Raised: $7 million Units: 9.4 million Price: $0.75 (unit) Shares after offering: 21.7 million…

    Published on 7/20/2015
  • Discovery Laboratories completes follow-on

    Discovery Laboratories Inc. (NASDAQ:DSCO), Warrington, Pa. Business: Pulmonary Date completed: 2015-07-17 Type: Follow-on Raised: $35 million Units: 58.3 million Price: $0.60 (unit) Shares after offering: 104.2 million …

    Published on 7/20/2015
  • Guided Therapeutics completes

    Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga. Business: Diagnostic Date completed: 2015-06-30 Raised: $2.5 million Shares: 3,334 Price: $750 Shares outstanding prior: 113.7 million Placement agent: Ladenburg …

    Published on 7/20/2015
  • Immunocore completes venture financing

    Immunocore Ltd., Abingdon, U.K. Business: Cancer, Infectious Date completed: 2015-07-16 Type: Venture financing Raised: $320 million Investors: Woodford Investment Management; Malin; Eli Lilly and Co.; RTW Investments; …

    Published on 7/20/2015
  • MacroGenics completes follow-on

    MacroGenics Inc. (NASDAQ:MGNX), Rockville, Md. Business: Cancer, Autoimmune, Antibodies Date completed: 2015-07-14 Type: Follow-on Raised: $130.4 million Shares: 3.5 million Price: $37 Shares after offering: 33.6 …

    Published on 7/20/2015
  • Miraculins completes private placement of units

    Miraculins Inc. (TSX-V:MOM), Winnipeg, Manitoba Business: Diagnostic, Proteomics Date completed: 2015-07-14 Type: Private placement of units Raised: C$350,000 ($274,855) Units: 4.4 million Price: C$0.08 (unit) Shares …

    Published on 7/20/2015
  • NephroGenex completes follow-on

    NephroGenex Inc. (NASDAQ:NRX), Research Triangle Park, N.C. Business: Renal Date completed: 2015-07-16 Type: Follow-on Raised: $7.5 million Shares: 1.5 million Price: $5 Shares after offering: 10.4 million Underwriter: …

    Published on 7/20/2015
  • NeuroDerm completes follow-on

    NeuroDerm Ltd. (NASDAQ:NDRM), Ness Ziona, Israel Business: Neurology, Drug delivery Date completed: 2015-07-15 Type: Follow-on Raised: $66.9 million Shares: 3.9 million Price: $17 Shares after offering: 20.9 million …

    Published on 7/20/2015
  • Piqur completes venture financing

    Piqur Therapeutics AG, Basel, Switzerland Business: Cancer Date completed: 2015-07-16 Type: Venture financing Raised: CHF18 million ($19 million) Investors: Versant Ventures; existing investors; new investors Note: The …

    Published on 7/20/2015
  • ProNAi completes IPO

    ProNAi Therapeutics Inc. (NASDAQ:DNAI), Vancouver, B.C. Business: Cancer Date completed: 2015-07-15 Type: IPO Raised: $137.7 million Shares: 8.1 million Price: $17 Shares after offering: 28.8 million Underwriters: …

    Published on 7/20/2015
  • Protagonist Therapeutics completes venture financing

    Protagonist Therapeutics Inc., Milpitas, Calif. Business: Gastrointestinal, Autoimmune, Inflammation Date completed: 2015-07-16 Type: Venture financing Raised: $40 million Investors: Canaan Partners; Adage Capital …

    Published on 7/20/2015
  • RedHill completes follow-on

    RedHill Biopharma Ltd. (Tel Aviv:RDHL; NASDAQ:RDHL), Ramat Gan, Israel Business: Drug delivery, Gastrointestinal Date completed: 2015-07-16 Type: Follow-on Raised: $40 million Shares: 2.5 million Price: $16.25 Shares …

    Published on 7/20/2015
  • SiteOne completes venture financing

    SiteOne Therapeutics Inc., San Francisco, Calif. Business: Neurology Date completed: 2015-07-15 Type: Venture financing Raised: Not disclosed Investors: Next Frontier Capital; 2M Companies; Sears Capital Management; …

    Published on 7/20/2015
  • SynTheAll Pharmaceuticals completes private placement

    Shanghai SynTheAll Pharmaceuticals Co. Ltd., Shanghai, China Business: Supply/Service, Chemistry Date completed: 2015-07-10 Type: Private placement Raised: RMB498.7 million ($80.3 million) Shares: 7.2 million Investor: …

    Published on 7/20/2015
  • Synthetic Biologics completes follow-on

    Synthetic Biologics Inc. (NYSE-M:SYN), Rockville, Md. Business: Infectious, Autoimmune, Gastrointestinal Date completed: 2015-07-16 Type: Follow-on Raised: $39.9 million Shares: 13.3 million Price: $3 Shares after …

    Published on 7/20/2015
  • Tonix completes follow-on

    Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), New York, N.Y. Business: Musculoskeletal, Neurology Date completed: 2015-07-14 Type: Follow-on Raised: $17.4 million Shares: 2.3 million Price: $7.50 Shares after …

    Published on 7/20/2015
  • Trovagene completes follow-on

    Trovagene Inc. (NASDAQ:TROV), San Diego, Calif. Business: Diagnostic Date completed: 2015-07-17 Type: Follow-on Raised: $35 million Shares: 4 million Price: Not disclosed Shares after offering: 28.9 million Underwriters…

    Published on 7/20/2015
  • Ultragenyx completes follow-on

    Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Novato, Calif. Business: Musculoskeletal, Endocrine/Metabolic Date completed: 2015-07-15 Type: Follow-on Raised: $264 million Shares: 2.2 million Price: $120 Shares after …

    Published on 7/20/2015
  • Vermillion completes follow-on

    Vermillion Inc. (NASDAQ:VRML), Austin, Texas Business: Diagnostic Date completed: 2015-07-14 Type: Follow-on Raised: $16.4 million Shares: 8.4 million Price: $1.96 Shares after offering: 50.6 million Underwriters: …

    Published on 7/20/2015
  • Anthera financial update

    Anthera Pharmaceuticals Inc. (NASDAQ:ANTH), Hayward, Calif. Business: Autoimmune, Cardiovascular Date announced: 2015-07-14 Note: Anthera raised $3.8 million through the sale of 500,000 shares at $7.50 to cover the …

    Published on 7/20/2015
  • Atara Biotherapeutics financial update

    Atara Biotherapeutics Inc. (NASDAQ:ATRA), Brisbane, Calif. Business: Cancer, Renal Date announced: 2015-07-15 Note: Atara raised $27 million through the sale of 519,230 shares at $52 to cover the overallotment from its …

    Published on 7/20/2015
  • Autifony financial update

    Autifony Therapeutics Ltd., London, U.K. Business: Other Date announced: 2015-07-10 Note: Autifony raised L8 million ($12.4 million) in an extension of a series A round, bringing the total raised to about L23.8 million…

    Published on 7/20/2015
  • Imperial Innovations financial update

    Imperial Innovations Group plc (LSE:IVO), London, U.K. Business: Finance, Other Date announced: 2015-07-14 Note: Imperial Innovations secured a two-year, L50 million ($77.6 million) loan from the European Investment …

    Published on 7/20/2015

< Previous   1  2  3  4  5  6  7  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993